Company Profile
Public information reviewed
Monte Rosa Therapeutics, Inc.
Canonical company identity and public leadership record.
USNASDAQ: GLUE
Follow
More
- Public sources
- 1 reviewed
- Published leadership records
- 25
- Last reviewed
- Sep 15, 2026
Agent View
Machine representations
Inspect the same governed public record as Markdown, structured data, or a retrieval endpoint.
Markdown
https://registry.alpha.ac/companies/monte-rosa-therapeutics-inc.mdMonte Rosa Therapeutics, Inc.
Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.
Record
| Field | Value |
|---|---|
| Representation | alpha-profile-markdown-v3 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1 |
| Canonical entity | alpha:company:4c73d323-73f1-488a-bdd2-da194d006937 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/monte-rosa-therapeutics-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 28 |
| Claims under review | 1 |
| Evidence records | 4 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-09-15T20:38:23.507277+00:00 |
| Last reviewed | 2026-09-15T20:38:23.507277+00:00 |
Identity
- Legal name: Monte Rosa Therapeutics, Inc.
- Display name: Monte Rosa Therapeutics, Inc.
Leadership
- Andrew Schiff: Non-Executive Chair of the Board. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:2.
- Ali Behbahani: Director. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:3.
- Anthony Manning: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:2.
- Anthony Manning, Ph.D.: Director. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:3.
- Chandra P. Leo: Director. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:3.
- Christine Siu: Director. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:3.
- Eric Hughes: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:2.
- Eric Hughes, M.D., Ph.D.: Director. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:3.
- Jan Skvarka: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:2.
- Kimberly L. Blackwell: Director. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:3.
- Markus Warmuth: Chief Executive Officer, President and Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:2.
- Markus Warmuth, M.D.: Director. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:3.
- Anthony Manning, Ph.D.: Named Executive Officer / Director Nominee. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:4.
- Champoux: Chief Operating Officer. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:4.
- Eric Hughes, M.D., Ph.D.: Named Executive Officer. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:4.
- Filip Janku: Chief Medical Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:2.
- Filip Janku, M.D., Ph.D.: Named Executive Officer. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:4.
- Jan Skvarka, Ph.D., MBA: Named Executive Officer. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:4.
- Jennifer Champoux: Chief Operating Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:2.
- Markus Warmuth: Chief Executive Officer and President. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:2.
- Markus Warmuth, M.D.: Chief Executive Officer. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:4.
- Philip Nickson: Chief Business and Legal Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:2.
- Philip Nickson, J.D., Ph.D.: Chief Business and Legal Officer. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:4.
- Sharon Townson: Chief Scientific Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:2.
- Townson: Chief Scientific Officer. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:4.
Roles
- PUBLISHED
Governance
- NOT_ASSERTED
Board committees
- PUBLISHED
Financials
- NOT_ASSERTED
Workforce
- NOT_ASSERTED
Market and index context
- PUBLISHED
Legal Name
- Monte Rosa Therapeutics, Inc.. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:1.
Headquarters
- US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review.
Entity Status
- Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:1.
Published Fact
- US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:1.
Coverage states
| Field | Value |
|---|---|
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |
Public sources
- alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:1: Alpha canonical company public projection.
- alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:2: SEC DEF 14A 0001193125-26-191439.
- alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:3: DEF 14A glue-20260429.htm.
- alpha:evidence:company:4c73d323-73f1-488a-bdd2-da194d006937:4: GLUE DEF 14A executive officers.
Rights
| Field | Value |
|---|---|
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |
Limitations
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
Alternate representations
- Canonical profile
- Public Markdown
- Public JSON
- JSON-LD
- MCP resource:
alpha://companies/monte-rosa-therapeutics-incat https://mcp.alpha.ac/mcp